270 related articles for article (PubMed ID: 28052660)
1. Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.
Hwang IK; Hahn SM; Kim HS; Kim SK; Kim HS; Shin KH; Suh CO; Lyu CJ; Han JW
Cancer Res Treat; 2017 Jul; 49(3):717-726. PubMed ID: 28052660
[TBL] [Abstract][Full Text] [Related]
2. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
Miao R; Wang H; Jacobson A; Lietz AP; Choy E; Raskin KA; Schwab JH; Deshpande V; Nielsen GP; DeLaney TF; Cote GM; Hornicek FJ; Chen YE
Radiother Oncol; 2019 Aug; 137():61-70. PubMed ID: 31078939
[TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.
Matsumine A; Kusuzaki K; Nakamura T; Nakazora S; Niimi R; Matsubara T; Uchida K; Murata T; Kudawara I; Ueda T; Naka N; Araki N; Maeda M; Uchida A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):891-900. PubMed ID: 19101731
[TBL] [Abstract][Full Text] [Related]
7. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
8. Malignant peripheral nerve sheath tumors: Analysis of the national cancer database.
Mowery A; Clayburgh D
Oral Oncol; 2019 Nov; 98():13-19. PubMed ID: 31525622
[TBL] [Abstract][Full Text] [Related]
9. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
10. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
[TBL] [Abstract][Full Text] [Related]
11. Malignant peripheral nerve sheath tumor: analysis of treatment outcome.
Wong WW; Hirose T; Scheithauer BW; Schild SE; Gunderson LL
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):351-60. PubMed ID: 9788415
[TBL] [Abstract][Full Text] [Related]
12. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis.
Doorn PF; Molenaar WM; Buter J; Hoekstra HJ
Eur J Surg Oncol; 1995 Feb; 21(1):78-82. PubMed ID: 7851559
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
[TBL] [Abstract][Full Text] [Related]
14. Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases.
Schaefer IM; Fletcher CD
Am J Surg Pathol; 2015 Sep; 39(9):1234-41. PubMed ID: 25929351
[TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
16. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
[TBL] [Abstract][Full Text] [Related]
17. Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients.
Shurell E; Tran LM; Nakashima J; Smith KB; Tam BM; Li Y; Dry SM; Federman N; Tap WD; Wu H; Eilber FC
BMC Cancer; 2014 Nov; 14():827. PubMed ID: 25398666
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
[TBL] [Abstract][Full Text] [Related]
19. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.
Plaat BE; Molenaar WM; Mastik MF; Hoekstra HJ; te Meerman GJ; van den Berg E
Int J Cancer; 1999 Oct; 83(2):171-8. PubMed ID: 10471523
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
